Intellectual Property India Publishes Patent Application for 'Interleukin Formulations For In Vivo Use' Filed by Akron Bioproducts Llc

MUMBAI, India, Aug. 29 -- Intellectual Property India has published a patent application (202517071921 A) filed by Akron Bioproducts Llc, Boca Raton, U.S.A., on July 29, for 'interleukin formulations for in vivo use.'

Inventor(s) include Zylberberg, Claudia; Vega, Julio Cesar; Li Causi, Mariana Laura; Kaufmann, Ingrid Gisela; Rodriguez, Juan Manuel; Zylberberg, Ezequiel; and Roufai, Mahajoub Bello.

The application for the patent was published on Aug. 29, under issue no. 35/2025.

According to the abstract released by the Intellectual Property India: "Stable liquid formulation for interleukin-2 (IL-2), interleukin-7 (IL-7), interleukin-15 (IL-15), and interleukin-21 (IL-21) for in vivo use are provided."

The patent application was internationally filed on Feb. 14, 2024, under International application No.PCT/US2024/015823.

Disclaimer: Curated by HT Syndication.